Skip to contentC
Collegium Pharmaceutical, Inc
C
COLLCollegium Pharmaceutical, Inc Q2 2018 · 10-Q
Revenue$73.06M$73.06M+1,952.3% vs Q2 2017 Net Income-$13.06M-$13.06MN/M vs Q2 2017 EPS Diluted-$0.40-$0.40N/M vs Q2 2017 Operating Income-$7,293,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Collegium Pharmaceutical, Inc · CIK 1267565 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$54,974,000N/M Margins · derivedOperating margin-10.0%+587.2 pt vs Q2 2017
Net margin-17.9%+575.4 pt vs Q2 2017
ended Jun 30, 2018 · filed Aug 8, 2018 · 39 d after period end